Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making
Project Number5R01EB029699-04
Former Number1R01EB029699-01
Contact PI/Project LeaderRASHIDI, PARISA Other PIs
Awardee OrganizationUNIVERSITY OF FLORIDA
Description
Abstract Text
Project Summary
Although close monitoring and dynamic assessment of patient acuity are key aspects of ICU care, both are
limited by the time constraints imposed on healthcare providers. Currently, dynamic and precise assessment of
patient’s acuity in ICU rely almost exclusively on physicians’ clinical judgment and vigilance. Furthermore,
important visual assessment details, such as facial expressions, posture, and mobility, are captured
sporadically by overburdened nurses or are not captured at all. However, these visual assessment details are
associated with critical indices such as physical function, pain and subsequent clinical deterioration. The PIs’
long-term goal is to sense, quantify, and communicate patient’s clinical condition in an autonomous and
precise manner. The overall objective of this application is to develop the novel tools for sensing, quantifying,
and communicating any patient’s condition in an autonomous, precise, and interpretable manner. The central
hypothesis is that deep learning models will be superior to existing acuity clinical scores by predicting acuity in
a dynamic, precise, and interpretable manner, using autonomous assessment of pain, emotional distress and
physical function, together with clinical and physiologic data. The hypothesis has been formulated based on
preliminary data and is well-grounded in clinical care literature. The rationale is that autonomous and precise
patient quantification can result in enhanced clinical workflow and early intervention. The overall objective will
be achieved by pursuing three specific aims. (1) Developing and validating an interpretable deep learning
algorithm for precise and dynamic prediction of the patient’s clinical status to determine if it is more accurate in
predicting daily care transition outcomes, while providing interpretable information to the physician. (2)
Developing a pervasive sensing system for autonomous visual assessment of critically ill patients to determine
if it can provide accurate visual assessment of a patient compared to human expert, and if it can enrich acuity
prediction when combined with clinical data. (3) Implementing and evaluating an intelligent platform for real-
time integration of autonomous visual assessment and acuity prediction in clinical workflow to determine
accuracy in real-time prospective evaluation and to determine physicians’ risk perception and satisfaction. The
approach is innovative, because it represents the first attempt to (1) dynamically predict precise patient
trajectory, (2) autonomously perform visual assessment in the ICU, and (3) implement artificial intelligence
platform in real time in clinical workflow. The proposed research is significant since it will address several key
problems and critical barriers in critical care, including (1) lack of precise and real-time prediction of clinical
trajectory, (2) manual repetitive ICU assessments, and (3) uncaptured patient aspects. Ultimately, the results
are expected to improve patient outcomes and decrease hospitalization costs, as well as lifelong
complications.
Public Health Relevance Statement
Project Narrative
The proposed research is relevant to public health because it can result in enhanced critical care workflow and
early critical care intervention, ultimately improving patient outcomes and decreasing hospitalization costs.
Thus, the proposed research is relevant to the part of NIH’s mission that pertains to advancing disease
diagnosis through medical applications of new tools and technologies, as the proposed research applies
advanced computational methods and sensing technologies to automatically quantify and convey patient
status in real-time.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
969663814
UEI
NNFQH1JAPEP3
Project Start Date
01-April-2021
Project End Date
31-December-2025
Budget Start Date
01-January-2024
Budget End Date
31-December-2025
Project Funding Information for 2024
Total Funding
$587,345
Direct Costs
$395,354
Indirect Costs
$191,991
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$587,345
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB029699-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB029699-04
Patents
No Patents information available for 5R01EB029699-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB029699-04
Clinical Studies
No Clinical Studies information available for 5R01EB029699-04
News and More
Related News Releases
No news release information available for 5R01EB029699-04
History
No Historical information available for 5R01EB029699-04
Similar Projects
No Similar Projects information available for 5R01EB029699-04